Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs.

导出 OA

翻译打印收藏纠错

作者： Yue,Ma ^[1] ; Jiting,Zhou ^[2] ; Yuxin,Ye ^[1] ; Aixia,Ma ^[2] ; Hongchao,Li ^[1]

作者单位： School of International Pharmaceutical Business, Jiangning District, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, Jiangsu, China. ^[1] Center for Pharmacoeconomics and Outcomes Research of China Pharmaceutical University, Nanjing, 211198, Jiangsu, China. ^[2] School of International Pharmaceutical Business, Jiangning District, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, Jiangsu, China. lihongchao@cpu.edu.cn. ^[3] Center for Pharmacoeconomics and Outcomes Research of China Pharmaceutical University, Nanjing, 211198, Jiangsu, China. lihongchao@cpu.edu.cn. ^[4]

关键词 Anticancer drugs Budget impact analysis Duration of treatment Economic evaluation Reconstructed individual patient data Reimbursement

DOI 10.1186/s12962-023-00447-7

PMID 37303057

发布时间 2023-06-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交